Work

Protein tyrosine kinase 6 signaling in prostate cancer.

Year: 2020
Type: review
Abstract: null prostate tumors. PTEN targets activating phosphorylation of PTK6 and loss of PTEN subsequently leads to PTK6 activation. Different studies provide compelling evidence as to why PTK6 is a potential therapeutic target in prostate cancer. Here, we briefly review the advances and significance of PTK6 in prostate cancer.
Source: PubMed
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W3016404951
FWCI: 0.255
Cites: 58
Cited by: 18
Related to: 10